That is huge risk...it means companies allowing SCAMydx to used patent application rights, like TRD and TRD's partnering Advisers BCI have no incentive to stick around, and could potentially walk away with a little bit of lawyering, of course.
It is quite risky if SP does trickle below the warrant purchase level of .001
Only 2 alternatives as SP approaches .001, product release or RS. Based on past history, the 1st alternative seems to never materialize at SCAMydx.